Stock Market Reviews

Read and share opinions on MAIA (MAIA Biotechnology, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
  Nov 10, 2025
• MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  Oct 27, 2025
• MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
  Oct 23, 2025
• MAIA Biotechnology Announces $736,600 Private Placement
  Oct 13, 2025
• Cancer drug maker takes sudden pivot into crypto
  Oct 7, 2025
• MAIA Biotechnology Announces $2.25 Million Private Placement
  Sep 29, 2025
• MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
  Sep 24, 2025
• MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
  Sep 11, 2025
• MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
  Sep 5, 2025
• MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
  Aug 27, 2025
• MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy
  Aug 13, 2025
• MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer
  Jul 28, 2025
• MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy
  Jul 17, 2025
• MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer
  Jul 9, 2025
• MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress
  Jul 1, 2025
• MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board
  Jun 24, 2025
• MAIA Biotechnology, Roche sign supply agreement for cancer therapies
  Jun 19, 2025
• MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
  Jun 18, 2025